ROCHE Farmaceutica Quimica, Lda secures contract for Antineoplastic and immunomodulating agents - 2023/0491- OBINUTUZUMAB [25 MG/ML; 40 ML; SOL INJ; FRS]

Portugal, July 1 -- Portugal based ROCHE Farmaceutica Quimica, Lda has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491- OBINUTUZUMAB [25 MG/ML; 40 ML; SOL INJ; FRS]. The value of the contract is worth 40059600 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....